Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06457841 · ClinicalTrials.gov registry record · NA
Stress and Resilience
A NA study of Cannabis Use and Alcohol Use, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 456
- Enrollment target
- 2
- Study locations
NCT06457841: Recruiting NA study of Cannabis Use and Alcohol Use, sponsored by University of Washington.
NCT06457841 is a NA study of Cannabis Use and Alcohol Use that is actively recruiting participants, run by University of Washington. The registered enrollment target is 456 participants, above the 269-participant average among 44 other Cannabis Use trials with a reported enrollment target (70% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06457841, a NA study of Cannabis Use and Alcohol Use, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 456 participants
- Enrollment target
- 2
- Study locations
Study Summary
Alcohol and cannabis are the most misused psychoactive substances in the United States. The proposed research examines how personally relevant stressful experiences may lead to alcohol and cannabis use. The proposed research is also designed to identify possible targets for prevention and treatment efforts to help reduce drug use.
Primary Outcome
Momentary Alcohol and Cannabis Craving Scale will be administered (adapted from the Momentary Cannabis Craving Scale; Davis et al., 2024) immediately after the intervention. Mean scores will range from 1 to 7, with higher scores indicating greater momentary craving.
Conditions Studied
Interventions
- BEHAVIORAL Direct Interpersonal Exchange
- BEHAVIORAL Vicarious Interpersonal Exchange
- BEHAVIORAL Daily Hassles
Study Locations (2)
Texas
- Southern Methodist University - Dallas
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 456 participants |
| Start Date | 2024-05-09 |
| Est. Completion | 2027-07 |
| Phase | NA |
What NCT06457841 shows while recruiting
NCT06457841 is an interventional study that assigns participants to a tested intervention. The registered 456 participants enrollment target is mid-sized for trials with a published cap, above the 269-participant average among 44 other Cannabis Use trials with a reported enrollment target (70% higher).
The record links to 2 conditions, with Cannabis Use appearing as the primary indexed condition, and to 3 interventions - of which Direct Interpersonal Exchange is the first listed.
NCT06457841 reports a single indexed study location in Texas, Washington.
Frequently Asked Questions
What is clinical trial NCT06457841 about?
NCT06457841 is a clinical study titled "Stress and Resilience". Alcohol and cannabis are the most misused psychoactive substances in the United States. The proposed research examines how personally relevant stressful experiences may lead to alcohol and cannabis use. The proposed research is also designed to identify possible targets for prevention and treatment ...
What is the current status of trial NCT06457841?
This trial is currently recruiting. It is a NA study. The enrollment target is 456 participants. The study started on 2024-05-09. Estimated completion is 2027-07.
What conditions does trial NCT06457841 study?
This clinical trial studies the following conditions: Cannabis Use, Alcohol Use.
What interventions are being tested in trial NCT06457841?
The interventions under investigation include: Direct Interpersonal Exchange (BEHAVIORAL), Vicarious Interpersonal Exchange (BEHAVIORAL), Daily Hassles (BEHAVIORAL).
Who is sponsoring clinical trial NCT06457841?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06457841 being conducted?
This trial has 2 study locations across Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06457841's enrollment target sits among peer trials
456 6th of 44 higher than 39 of 44 other Cannabis Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility/Acceptability of a Brief Motivational Intervention for Frequent/High-Intensity Cannabis Use
RECRUITING · NA
-
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Cannabis THC Potency, Metabolism, and Cognitive Impairment in Young Adults
RECRUITING · NA
-
Perceptual Influences From Smoking Cannabis: an Experimental Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04462302 · 456 participants · NA
An Internet-based Program to Help Cancer Survivors Manage Pain
- NCT05820919 · 456 participants · NA
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- NCT06254612 · 456 participants · Phase 2
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
- NCT05541016 · 455 participants · Phase 2
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI